Assay for quantitative measurement of analytes in biological samples

• US 6,127,140 A
• Filed: 06/18/1999
• Issued: 10/03/2000
• Est. Priority Date: 06/18/1999
• Status: Expired due to Term

• Current Assignee: Abbott Laboratories Incorporated
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Leahy, David C., Massie, Donna M., Vidakovic, Momcilo S.
• Primary Examiner(s): Leary, Louise N.
• Application Number:
  US09/335,584
• Time in Patent Office: 473 Days
• Field of Search: 435/25, 435/14, 435/968, 435/11, 435/22, 552/502, 436/71, 568/303
• US Class Current: 435/25
• CPC Class Codes: C12Q 1/26 involving oxidoreductase
• CPC Class Codes: C12Q 1/32 involving dehydrogenase
• CPC Class Codes: Y10S 435/968 High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Abstract

A method for determining concentration of an analyte in a biological sample comprising the steps of:

(a) combining the biological sample, at least one oxidizing enzyme for the analyte of interest, nicotinamide adenine dinucleotide (hereinafter NAD⁺), and a chemiluminescent label to form a reaction mixture;

(b) allowing the analyte to undergo an oxidation-reduction reaction and NAD⁺ to be converted to the reduced form of nicotinamide adenine dinucleotide (hereinafter NADH) and further allowing the chemiluminescent label to react with NADH; and

(c) determining the concentration of the analyte of interest in the biological sample by correlating the quantity of light emitted with the concentration of NADH.

Claims

1. A method for determining concentration of an analyte in a biological sample comprising the steps of:

(a) combining the biological sample, at least one oxidizing enzyme for the analyte of interest, nicotinamide adenine dinucleotide, and a chemiluminescent label to form a reaction mixture;

(b) allowing the analyte to undergo an oxidation-reduction reaction and nicotinamide adenine dinucleotide to be converted to the reduced form of nicotinamide adenine dinucleotide and further allowing the chemiluminescent label to react with the reduced form of nicotinamide adenine dinucleotide; and

(c) determining the concentration of the analyte of interest in the biological sample by correlating the quantity of light emitted with the concentration of the reduced form of nicotinamide adenine dinucleotide.

2. The method of claim 1, wherein said chemiluminescent label is added to said reaction mixture subsequent to the commencing of the formation of the reduced form of nicotinamide adenine dinucleotide.

3. The method of claim 1, wherein said analyte is selected from the group consisting of ethanol, ethylene glycol, phenytoin, glucose, ketone bodies, triglycerides, cholesterol, lactate, α

-amylase, ammonia, malate, androsterone, and testosterone.

4. The method of claim 1, wherein said analyte is ethanol.

5. The method of claim 1, further including the step of adding a trapping agent to the reaction mixture of step (a).

6. The method of claim 1, wherein said chemiluminescent label is a derivative of luminol or a derivative of acridine.

7. The method of claim 1, wherein said label is deactivated by reduction.

8. The method of claim 1, wherein said chemiluminescent label comprises an acridinium derivative.

9. The method of claim 1, wherein said chemiluminescent label comprises an acridinium conjugate.

10. The method of claim 1, wherein said reaction mixture is maintained at a pH equal to or greater than 9.

11. The method of claim 1, wherein a buffer is included in the reaction mixture.

12. The method of claim 1, wherein a pre-trigger is employed to condition the chemiluminescent label for reaction with alkaline peroxide.

13. The method of claim 1, wherein a trigger is employed to cause the chemiluminescent label to react with a nucleophile, thereby allowing the formation of a compound that emits light.

14. The method of claim 11, wherein the trigger is alkaline peroxide.

15. A method for determining concentration of an analyte in a biological sample comprising the steps of:

(a) combining the biological sample, a solid phase, at least one oxidizing enzyme for the analyte of interest, nicotinamide adenine dinucleotide, and a chemiluminescent label to form a reaction mixture;

(b) allowing the analyte to undergo an oxidation-reduction reaction and nicotinamide adenine dinucleotide to be converted to the reduced form of nicotinamide adenine dinucleotide and further allowing the chemiluminescent label to react with the reduced form of nicotinamide adenine dinucleotide;

(c) separating the chemiluminescent label from the solid phase; and

(d) determining the concentration of the analyte in the biological sample by correlating quantity of light emitted with the concentration of the reduced form of nicotinamide adenine dinucleotide.

16. The method of claim 15, wherein said chemiluminescent label is added to said reaction mixture subsequent to the commencing of the formation of the reduced form of nicotinamide adenine dinucleotide.

17. The method of claim 15, wherein said analyte is selected from the group consisting of ethanol, ethylene glycol, phenytoin, glucose, ketone bodies, triglycerides, cholesterol, lactate, alpha-amylase, ammonia, malate, androsterone, and testosterone.

18. The method of claim 15, wherein said analyte is ethanol.

19. The method of claim 15, further including the step of adding a trapping agent to the reaction mixture of step (a).

20. The method of claim 15, wherein said chemiluminescent label is a derivative of luminol or a derivative of acridine.

21. The method of claim 15, wherein said label wherein said label is deactivated by reduction.

22. The method of claim 15, wherein said chemiluminescent label comprises an acridinium derivative.

23. The method of claim 15, wherein said chemiluminescent label comprises an acridinium conjugate.

24. The method of claim 15, wherein said reaction mixture is maintained at a pH equal to or greater than 9.

25. The method of claim 15, wherein a buffer is included in the reaction mixture.

26. The method of claim 15, wherein a pre-trigger wherein a pre-trigger is employed to condition the chemiluminescent label for reaction with alkaline peroxide.

27. The method of claim 15, wherein a trigger is employed to cause the chemiluminescent label to react with a nucleophile, thereby allowing the formation of a compound that emits light.

28. The method of claim 27, wherein said trigger is alkaline peroxide.